Jim Simons Bausch Health Companies Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 760,983 shares of BHC stock, worth $4.57 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
760,983
Previous 909,572
16.34%
Holding current value
$4.57 Million
Previous $5.88 Million
13.87%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding BHC
# of Institutions
251Shares Held
243MCall Options Held
2.44MPut Options Held
8.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$209 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$206 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$197 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$129 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$78.1 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.17B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...